Skip to main content

Table 3 Correlation analysis of ANK2 and marker s of multiple immune cells in LUAD by TIMER

From: ANK2 as a novel predictive biomarker for immune checkpoint inhibitors and its correlation with antitumor immunity in lung adenocarcinoma

Description

Gene markers

rho

P value

T cell

CD3D

0.342

1.50E−15

CD3E

0.442

4.77E−26

CD2

0.391

3.27E−20

CD8+ T cell

CD8A

0.316

2.05E−13

CD8B

0.268

6.18E−10

IL2RA

0.362

2.41E−17

Tfh

CXCR3

0.367

7.08E−18

CXCR5

0.47

1.06E−29

ICOS

0.417

4.14E−23

Th1

IL12RB1

0.404

1.21E−21

CCR1

0.34

2.04E−15

CCR5

0.425

5.84E−24

Th2

CCR4

0.474

3.14E−30

CCR8

0.426

4.48E−24

HAVCR1

0.04

3.62E−01

Th17

IL21R

0.4

3.03E−21

IL23R

0.306

1.37E−12

CCR6

0.483

1.69E−31

B cell

CD19

0.455

1.01E−27

CD79A

0.429

1.77E−24

Monocyte

CD86

0.36

3.28E−17

CSF1R

0.385

1.31E−19

Natural killer cell

KIR2DL1

0.143

1.11E−03

KIR2DL3

0.167

1.16E−04

KIR2DL4

0.079

7.31E−02

KIR3DL1

0.081

6.65E−02

KIR3DL2

0.182

3.26E−05

KIR2DS4

0.156

3.86E−04

Dendritic cell

HLA-DPB1

0.36

3.41E−17

HLA-DQB1

0.262

1.49E−09

HLA-DRA

0.299

4.10E−12

HLA-DPA1

0.342

1.28E−15

CD1C

0.312

4.20E−13

NRP1

0.247

1.28E−08

ITGAX(CD11C)

0.402

2.22E−21